Samuel Brito de Almeida
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Samuel Brito de Almeida has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
- Pedro Braga-Neto
Clinical Medicine, Universidade Federal do Ceara, Rua Professor Costa Mendes 1608, 4th floor, Rodolfo Teofilo, Fortaleza, CE, 60430-140, Brazil
9 shared publications - Danielle Pessoa Lima
Universidade Federal do Ceará
7 shared publications - Antonio Brazil Viana Júnior
Universidade Federal do Ceará
4 shared publications - Janine de Carvalho Bonfadini
Universidade Federal do Ceará (UFC), Empresa Brasileira de Serviços Hospitalares (EBSERH), Fortaleza, Ceará, Brasil
4 shared publications - Jarbas de Sá Roriz Filho
Department of Internal Medicine, Division of Geriatrics Federal University of Ceará Fortaleza Ceará Brazil
4 shared publications - Alexandre Henrique Silva Carneiro
Universidade Federal do Ceará, Brazil
3 shared publications
Latest Publications
- Open Access
- 27 February 2026
- Published by Georg Thieme Verlag KG in Arquivos de Neuro-Psiquiatria
- Vol. 84 (02) , 001-011
Clinical correlates of physical performance and sarcopenia in Parkinson's disease: a cross-sectional study
Parkinson's disease (PD) presents motor and non-motor symptoms that impair function and quality of life. Identifying clinical factors linked to physical performance is key for patient care and management. To examine associations between sarcopenia-related measures and physical performance in mild-to-moderate PD (Hoehn & Yahr [HY] I–III). This was a cross-sectional study including patients with idiopathic Parkinson's disease at mild to moderate stages (Hoehn & Yahr I–III), evaluated in the ON medication state. Physical performance was assessed using the Short Physical Performance Battery (SPPB). Sarcopenia was evaluated according to the revised European Working Group on Sarcopenia in Older People (EWGSOP2) consensus, including screening with the SARC-F questionnaire and the Ishii score, assessment of muscle strength by handgrip dynamometry, and evaluation of body composition and appendicular lean mass by whole-body dual-energy X-ray absorptiometry (DXA). Analyses included bivariate comparisons, correlation analyses, and logistic regression models (Enter and Best Subsets). A total of 127 patients were evaluated (mean age 66 years; 41.7% females). Low physical performance was observed in 39% (n = 50) of patients and was strongly associated with positive screening of sarcopenia (SARC-F score ≥ 4; odds ratio [OR]: 1.67; 95%CI: 1.30–2.15; p < 0.001). Ishii score (p = 0.009), reduced mean handgrip strength (26 ± 10 kgf versus 30 ± 10 kgf; p = 0.02), and postural instability and gait difficulty (PIGD) (p < 0.001) were also significantly associated with low SPPB performance in bivariate analyses. In the multivariable models, SARC-F and PIGD emerged as independent predictors of poor physical performance. The best subset model, combining SARC-F and PIGD, showed good discriminative accuracy (area under the curve [AUC] = 0.82). Higher PIGD scores and SARC-F ≥ 4 correlated with poor physical performance in PD. Low performance was linked to both SARC-F and Ishii scores, which help identify risk of functional decline. Longitudinal studies are needed to clarify causality and treatment implications.
- 27 February 2026
- Published by Georg Thieme Verlag KG in Arquivos de Neuro-Psiquiatria
- Vol. 84 (02) , 001-011
Open AccessClinical correlates of physical performance and sarcopenia in Parkinson's disease: a cross-sectional study
Parkinson's disease (PD) presents motor and non-motor symptoms that impair function and quality of life. Identifying clinical factors linked to physical performance is key for patient care and management. To examine associations between sarcopenia-related measures and physical performance in mild-to-moderate PD (Hoehn & Yahr [HY] I–III). This was a cross-sectional study including patients with idiopathic Parkinson's disease at mild to moderate stages (Hoehn & Yahr I–III), evaluated in the ON medication state. Physical performance was assessed using the Short Physical Performance Battery (SPPB). Sarcopenia was evaluated according to the revised European Working Group on Sarcopenia in Older People (EWGSOP2) consensus, including screening with the SARC-F questionnaire and the Ishii score, assessment of muscle strength by handgrip dynamometry, and evaluation of body composition and appendicular lean mass by whole-body dual-energy X-ray absorptiometry (DXA). Analyses included bivariate comparisons, correlation analyses, and logistic regression models (Enter and Best Subsets). A total of 127 patients were evaluated (mean age 66 years; 41.7% females). Low physical performance was observed in 39% (n = 50) of patients and was strongly associated with positive screening of sarcopenia (SARC-F score ≥ 4; odds ratio [OR]: 1.67; 95%CI: 1.30–2.15; p < 0.001). Ishii score (p = 0.009), reduced mean handgrip strength (26 ± 10 kgf versus 30 ± 10 kgf; p = 0.02), and postural instability and gait difficulty (PIGD) (p < 0.001) were also significantly associated with low SPPB performance in bivariate analyses. In the multivariable models, SARC-F and PIGD emerged as independent predictors of poor physical performance. The best subset model, combining SARC-F and PIGD, showed good discriminative accuracy (area under the curve [AUC] = 0.82). Higher PIGD scores and SARC-F ≥ 4 correlated with poor physical performance in PD. Low performance was linked to both SARC-F and Ishii scores, which help identify risk of functional decline. Longitudinal studies are needed to clarify causality and treatment implications.
- Open Access
- 25 January 2026
- Published by Georg Thieme Verlag KG in Arquivos de Neuro-Psiquiatria
- Vol. 84 (01) , 001-007
Brazilian version of the Fear of Falls Scale: translation, cross-cultural adaptation and validation
Fear of falling can be present in the daily lives of patients with Parkinson's disease (PD) due to their predisposition to falls. The main objective of this study was to translate the Fear of Falls Scale (FFS) into Brazilian Portuguese, adapt it cross-culturally, and validate it. A multicenter, cross-sectional study was conducted with PD patients fluent in Brazilian Portuguese, recruited from five research centers in Brazil. Descriptive analysis characterized the sample and compared the data. Cronbach's α and McDonald's ω coefficients were used to assess the internal consistency of the scale. No significant differences were observed between the translated versions T1 and T2. The B1 and B2 versions did not present significant divergences in the back-translation from the original scale. The Movement Disorder Society – Unified Parkinson Disease Rating Scale (MDS-UPDRS) part III significantly correlated with motor skills (rho = 0.56, 0.43–0.67; p ≤ 0.001) and fear of falling (rho = 0.48, 0.34–0.60; p ≤ 0.001). Higher stages on the modified Hoehn & Yahr scale were associated with a greater decline in motor skills and a greater fear of falling (p < 0.001). The total internal consistency of balance-related motor skills and fear of falling was considered sufficiently reliable. Cronbach's α values were 0.96, 0.91, and 0.90; while McDonald's ω values were 0.96, 0.92, and 0.91, respectively. The Brazilian version of the FFS proved to be valid and reliable for assessing fear of falling in people with PD.
- 25 January 2026
- Published by Georg Thieme Verlag KG in Arquivos de Neuro-Psiquiatria
- Vol. 84 (01) , 001-007
Open AccessBrazilian version of the Fear of Falls Scale: translation, cross-cultural adaptation and validation
Fear of falling can be present in the daily lives of patients with Parkinson's disease (PD) due to their predisposition to falls. The main objective of this study was to translate the Fear of Falls Scale (FFS) into Brazilian Portuguese, adapt it cross-culturally, and validate it. A multicenter, cross-sectional study was conducted with PD patients fluent in Brazilian Portuguese, recruited from five research centers in Brazil. Descriptive analysis characterized the sample and compared the data. Cronbach's α and McDonald's ω coefficients were used to assess the internal consistency of the scale. No significant differences were observed between the translated versions T1 and T2. The B1 and B2 versions did not present significant divergences in the back-translation from the original scale. The Movement Disorder Society – Unified Parkinson Disease Rating Scale (MDS-UPDRS) part III significantly correlated with motor skills (rho = 0.56, 0.43–0.67; p ≤ 0.001) and fear of falling (rho = 0.48, 0.34–0.60; p ≤ 0.001). Higher stages on the modified Hoehn & Yahr scale were associated with a greater decline in motor skills and a greater fear of falling (p < 0.001). The total internal consistency of balance-related motor skills and fear of falling was considered sufficiently reliable. Cronbach's α values were 0.96, 0.91, and 0.90; while McDonald's ω values were 0.96, 0.92, and 0.91, respectively. The Brazilian version of the FFS proved to be valid and reliable for assessing fear of falling in people with PD.
- Open Access
- 5 September 2025
- Published by Universidade Federal do Ceará (UFC) in Revista de Medicina da UFC
- Vol. 65, e93340
Desafios na educação em saúde na doença de Parkinson: construção e validação de um manual para pacientes
Objetivo: Desenvolver e validar material educativo destinado às pessoas com doença de Parkinson para facilitar o entendimento sobre a doença, incluindo quadro clínico, tratamento e terapêutica não farmacológica. Metodologia: Estudo metodológico com abordagem quantitativa e qualitativa desenvolvido em três etapas: construção do manual, validação por especialistas e validação pelo público-alvo. O manual “Viver com Parkinson” aborda os sintomas, o tratamento, as complicações e as estratégias de enfrentamento da doença de Parkinson. Resultados: O material obteve nível de concordância de 90,93% pelo julgamento dos especialistas e de 98,66% pelo público-alvo, sendo classificado com conceituação máxima por ambos os grupos. Os pacientes consideraram o manual informativo, explicativo e motivador para ações de autocuidado. Conclusão: O manual se mostrou válido quanto ao conteúdo e à aparência segundo especialistas e pacientes com doença de Parkinson, com potencial para promover mudanças adaptativas de autocuidado.
- 5 September 2025
- Published by Universidade Federal do Ceará (UFC) in Revista de Medicina da UFC
- Vol. 65, e93340
Open AccessDesafios na educação em saúde na doença de Parkinson: construção e validação de um manual para pacientes
Objetivo: Desenvolver e validar material educativo destinado às pessoas com doença de Parkinson para facilitar o entendimento sobre a doença, incluindo quadro clínico, tratamento e terapêutica não farmacológica. Metodologia: Estudo metodológico com abordagem quantitativa e qualitativa desenvolvido em três etapas: construção do manual, validação por especialistas e validação pelo público-alvo. O manual “Viver com Parkinson” aborda os sintomas, o tratamento, as complicações e as estratégias de enfrentamento da doença de Parkinson. Resultados: O material obteve nível de concordância de 90,93% pelo julgamento dos especialistas e de 98,66% pelo público-alvo, sendo classificado com conceituação máxima por ambos os grupos. Os pacientes consideraram o manual informativo, explicativo e motivador para ações de autocuidado. Conclusão: O manual se mostrou válido quanto ao conteúdo e à aparência segundo especialistas e pacientes com doença de Parkinson, com potencial para promover mudanças adaptativas de autocuidado.
- Open Access
- 29 August 2025
- Published by Universidade Federal do Ceará (UFC) in Revista de Medicina da UFC
- Vol. 65, e93149
PARK-BAND training program for Parkinson’s disease: a feasibility study
Objective: The purpose of this study was to identify primary endpoints related to feasibility of power training in patients with mild-to-moderate Parkinson Disease (PD). Methods: This is a pilot study of a randomized controlled trial blinded for data analyzers and outcome evaluators, lasting 12 weeks. We aim to compare power training to a health education program. The pre-planned primary endpoints of the Randomized Clinical Trial are the bradykinesia scores of the Unified Parkinson Disease Rating Scale (UPDRS) and Short Physical Performance Battery (SPPB). Participants were randomized to two groups: power training group (PTG) and health education group (HEG) in 1:1 ratio through a permuted block of 8 patients. Results: A total of 34 patients were screened and 8 were enrolled and randomized. Five (62.5%) were female and the median age was 66 (45–77) years. Attendance rate to HEG was 83.3% and to PTG 96.82%, adherence rate to HEG was 80% and to PTG 95.23%, retention rate was 75%. No adverse events were related to the intervention. Conclusions: PARK-BAND Training Program for Parkinson’s Disease: A Feasibility Study (PARK-BAND) pilot had reasonable acceptance, attendance, adherence, and safety rates to start. (REBEC number: RBR-5w2sq).
- 29 August 2025
- Published by Universidade Federal do Ceará (UFC) in Revista de Medicina da UFC
- Vol. 65, e93149
Open AccessPARK-BAND training program for Parkinson’s disease: a feasibility study
Objective: The purpose of this study was to identify primary endpoints related to feasibility of power training in patients with mild-to-moderate Parkinson Disease (PD). Methods: This is a pilot study of a randomized controlled trial blinded for data analyzers and outcome evaluators, lasting 12 weeks. We aim to compare power training to a health education program. The pre-planned primary endpoints of the Randomized Clinical Trial are the bradykinesia scores of the Unified Parkinson Disease Rating Scale (UPDRS) and Short Physical Performance Battery (SPPB). Participants were randomized to two groups: power training group (PTG) and health education group (HEG) in 1:1 ratio through a permuted block of 8 patients. Results: A total of 34 patients were screened and 8 were enrolled and randomized. Five (62.5%) were female and the median age was 66 (45–77) years. Attendance rate to HEG was 83.3% and to PTG 96.82%, adherence rate to HEG was 80% and to PTG 95.23%, retention rate was 75%. No adverse events were related to the intervention. Conclusions: PARK-BAND Training Program for Parkinson’s Disease: A Feasibility Study (PARK-BAND) pilot had reasonable acceptance, attendance, adherence, and safety rates to start. (REBEC number: RBR-5w2sq).
- Open Access
- 4 February 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (2) , e0314058
Effect of power training on physical functional performance of patients with Parkinson’s disease: A systematic review and meta-analysis of randomized controlled trials
Introduction: Parkinson’s disease (PD) is becoming more prevalent, highlighting the urgency of developing treatments to minimize its effects on muscular strength and physical function. Power training (PT) is a potential approach that may improve endurance and muscular power, essential for maintaining functional ability in PD. Objective: To compare the effect of PT versus control or other physical activity (PA) interventions on physical functional performance (PFP) in PD patients. Methods: We searched PubMed, MEDLINE, Embase, LILACS, PEDro, Cochrane Library, and Scopus. Inclusion criteria were randomized controlled trials comparing PT to a control group or another PA intervention in PD patients. PFP was the primary outcome. Pooled effect estimates were calculated from baseline to endpoint scores. Results: From 21,558 results, four studies were included in the meta-analysis due to their moderate to high methodological quality. PT showed no significant effect on PFP outcomes compared to control groups (TUG: ES, −0.281; 95% CI, −0.693 to 0.130; P = 0.180; I2:0%; PWS: ES, 0.748; 95% CI, −0.768 to 2.265; P = 0.333; I2:88%; FWS: ES, 0.420; 95% CI, −0.950 to 1.791; P = 0.548; I2:83%; SLS: ES, 0.161; 95% CI, −0.332 to 0.655; P = 0.521; I2:0%). No differences were found between PT and alternative interventions (TUG: ES, 0.132; 95% CI, −0.394 to 0.657; P = 0.623; I2:0%; BBA: ES, 0.057; 95% CI, −0.430 to 0.544; P = 0.820; I2:0%). Conclusion: PT did not improve PFP compared to control or alternative interventions. More studies are needed to explore PT effects (e.g., higher volume, intensity, and combined types) in PD patients.
- 4 February 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (2) , e0314058
Open AccessEffect of power training on physical functional performance of patients with Parkinson’s disease: A systematic review and meta-analysis of randomized controlled trials
Introduction: Parkinson’s disease (PD) is becoming more prevalent, highlighting the urgency of developing treatments to minimize its effects on muscular strength and physical function. Power training (PT) is a potential approach that may improve endurance and muscular power, essential for maintaining functional ability in PD. Objective: To compare the effect of PT versus control or other physical activity (PA) interventions on physical functional performance (PFP) in PD patients. Methods: We searched PubMed, MEDLINE, Embase, LILACS, PEDro, Cochrane Library, and Scopus. Inclusion criteria were randomized controlled trials comparing PT to a control group or another PA intervention in PD patients. PFP was the primary outcome. Pooled effect estimates were calculated from baseline to endpoint scores. Results: From 21,558 results, four studies were included in the meta-analysis due to their moderate to high methodological quality. PT showed no significant effect on PFP outcomes compared to control groups (TUG: ES, −0.281; 95% CI, −0.693 to 0.130; P = 0.180; I2:0%; PWS: ES, 0.748; 95% CI, −0.768 to 2.265; P = 0.333; I2:88%; FWS: ES, 0.420; 95% CI, −0.950 to 1.791; P = 0.548; I2:83%; SLS: ES, 0.161; 95% CI, −0.332 to 0.655; P = 0.521; I2:0%). No differences were found between PT and alternative interventions (TUG: ES, 0.132; 95% CI, −0.394 to 0.657; P = 0.623; I2:0%; BBA: ES, 0.057; 95% CI, −0.430 to 0.544; P = 0.820; I2:0%). Conclusion: PT did not improve PFP compared to control or alternative interventions. More studies are needed to explore PT effects (e.g., higher volume, intensity, and combined types) in PD patients.
- Open Access
- 14 May 2024
- Published by Springer Nature in BMC Neurology
- Vol. 24 (1) , 1-11
Effectiveness of vestibular rehabilitation on postural balance in Parkinson’s disease: a systematic review and meta-analysis of randomized controlled trials
Introduction: Postural balance impairment can affect the quality of life of patients with Parkinson’s disease. Previous studies have described connections of the vestibular system with postural functions, suggesting a potential participation of the basal ganglia in receiving vestibular stimuli. This systematic review aims to summarize the evidence on the effectiveness of vestibular rehabilitation on postural balance in patients with Parkinson’s disease. Methods: A systematic review was conducted using the electronic databases: PubMed, Embase, Scopus and PEDro. The study selection was independently conducted by two reviewers, and disagreements were evaluated by a third reviewer. The included studies had no restrictions on publication dates or languages and the last update occurred in July 2023. Results: From the 485 studies found in the searches, only 3 studies were deemed eligible for the systematic review involving a total of 130 participants. The Berg Balance Scale was described as the tool for evaluation of postural balance in all studies. The meta-analysis showed statistically significant results in favor of vestibular rehabilitation (MD = 5.35; 95% CI = 2.39, 8.31; P < 0.001), regardless of the stage of Parkinson’s disease. Although the effect size was suggested as a useful functional gain, the analysis was done with caution, as it only included 3 randomized controlled trials. The risk of bias using the RoB-2 was considered as being of “some concern” in all studies. Furthermore, the quality of the evidence based on the Grading of Recommendations Assessment Development and Evaluation system, produced by pooling the included studies was considered very low. Conclusion: Compared to other interventions, vestibular rehabilitation has potential to assist the postural balance of patients with Parkinson’s disease. However, the very low quality of the evidence demonstrates uncertainty about the impact of this clinical practice. More robust studies are needed to confirm the benefits of this therapy in patients with Parkinson’s disease. This study was prospectively registered in PROSPERO: CRD42020210185.
- 14 May 2024
- Published by Springer Nature in BMC Neurology
- Vol. 24 (1) , 1-11
Open AccessEffectiveness of vestibular rehabilitation on postural balance in Parkinson’s disease: a systematic review and meta-analysis of randomized controlled trials
Introduction: Postural balance impairment can affect the quality of life of patients with Parkinson’s disease. Previous studies have described connections of the vestibular system with postural functions, suggesting a potential participation of the basal ganglia in receiving vestibular stimuli. This systematic review aims to summarize the evidence on the effectiveness of vestibular rehabilitation on postural balance in patients with Parkinson’s disease. Methods: A systematic review was conducted using the electronic databases: PubMed, Embase, Scopus and PEDro. The study selection was independently conducted by two reviewers, and disagreements were evaluated by a third reviewer. The included studies had no restrictions on publication dates or languages and the last update occurred in July 2023. Results: From the 485 studies found in the searches, only 3 studies were deemed eligible for the systematic review involving a total of 130 participants. The Berg Balance Scale was described as the tool for evaluation of postural balance in all studies. The meta-analysis showed statistically significant results in favor of vestibular rehabilitation (MD = 5.35; 95% CI = 2.39, 8.31; P < 0.001), regardless of the stage of Parkinson’s disease. Although the effect size was suggested as a useful functional gain, the analysis was done with caution, as it only included 3 randomized controlled trials. The risk of bias using the RoB-2 was considered as being of “some concern” in all studies. Furthermore, the quality of the evidence based on the Grading of Recommendations Assessment Development and Evaluation system, produced by pooling the included studies was considered very low. Conclusion: Compared to other interventions, vestibular rehabilitation has potential to assist the postural balance of patients with Parkinson’s disease. However, the very low quality of the evidence demonstrates uncertainty about the impact of this clinical practice. More robust studies are needed to confirm the benefits of this therapy in patients with Parkinson’s disease. This study was prospectively registered in PROSPERO: CRD42020210185.
- Open Access
- 1 January 2023
- Published by FapUNIFESP (SciELO) in Dementia & Neuropsychologia
- Vol. 17, e20220084
Educational disparities in Brazil may interfere with the cognitive performance of Parkinson's disease patients
The prevalence of cognitive impairment in Parkinson's disease (PD) is about 20% to 60%. The Mini-Mental Status Examination (MMSE) is the most used cognitive screening test. Objective: To evaluate the influence of clinical and demographic characteristics, specifically the education level, on the MMSE score in PD patients of a northeast Brazilian sample. Methods: We performed a cross-sectional study of 198 PD patients at a Movement Disorders outpatient clinic in Fortaleza, CE, Brazil. Participants were assessed by detailed clinical history, modified Hoehn and Yahr staging (HY), geriatric depression scale (GDS) and MMSE. Results: We found that 68% of patients had MMSE scores below the Brazilian thresholds, which were based in Brucki et al. study (2003). There was a statistically significant difference in the bivariate analysis between educational level and cut-off classification for MMSE. More years of formal schooling were associated with more patients scoring below threshold. We found that 75%, 68.8%, and 79.7% of individuals with more than 11, 9 to 11, and 4 to 8 years of formal schooling, respectively, were below the suggested Brazilian Brucki's threshold. GDS and age were negatively correlated with total MMSE and all its domains. There was no correlation between disease duration and MMSE. Subjects with hallucinations had lower scores. Conclusion: Most of the sample had lower performance according to Brazilian thresholds, but there was no control group and no neuropsychological test in this study. Further studies in northeast Brazil are needed to review MMSE cut-off values.
- 1 January 2023
- Published by FapUNIFESP (SciELO) in Dementia & Neuropsychologia
- Vol. 17, e20220084
Open AccessEducational disparities in Brazil may interfere with the cognitive performance of Parkinson's disease patients
The prevalence of cognitive impairment in Parkinson's disease (PD) is about 20% to 60%. The Mini-Mental Status Examination (MMSE) is the most used cognitive screening test. Objective: To evaluate the influence of clinical and demographic characteristics, specifically the education level, on the MMSE score in PD patients of a northeast Brazilian sample. Methods: We performed a cross-sectional study of 198 PD patients at a Movement Disorders outpatient clinic in Fortaleza, CE, Brazil. Participants were assessed by detailed clinical history, modified Hoehn and Yahr staging (HY), geriatric depression scale (GDS) and MMSE. Results: We found that 68% of patients had MMSE scores below the Brazilian thresholds, which were based in Brucki et al. study (2003). There was a statistically significant difference in the bivariate analysis between educational level and cut-off classification for MMSE. More years of formal schooling were associated with more patients scoring below threshold. We found that 75%, 68.8%, and 79.7% of individuals with more than 11, 9 to 11, and 4 to 8 years of formal schooling, respectively, were below the suggested Brazilian Brucki's threshold. GDS and age were negatively correlated with total MMSE and all its domains. There was no correlation between disease duration and MMSE. Subjects with hallucinations had lower scores. Conclusion: Most of the sample had lower performance according to Brazilian thresholds, but there was no control group and no neuropsychological test in this study. Further studies in northeast Brazil are needed to review MMSE cut-off values.
- Open Access
- 1 June 2022
- Published by FapUNIFESP (SciELO) in Dementia & Neuropsychologia
- Vol. 16 (2) , 153-161
Falls in Parkinson's disease: the impact of disease progression, treatment, and motor complications
The prevalence of Parkinson's disease (PD) tends to increase worldwide in the coming decades. Thus, the incidence of falls is likely to increase, with a relevant burden on the health care system. Objective: The objective of this study was to evaluate clinical factors and drug use associated with falls in PD patients. Methods: We conducted a cross-sectional study at the Movement Disorders outpatient clinic of a tertiary hospital in Northeast Brazil. We performed structured interviews to collect sociodemographic and clinical data. Functional capacity was assessed using the Schwab and England Activities of Daily Living Scale and the modified Hoehn and Yahr Staging Scale. We divided the study sample into non-fallers (no falls) and fallers (≥1 fall), and non-recurrent (≤1 fall) and recurrent fallers (>1 fall). Results: The study population comprised 327 PD patients (48% women), with a mean age of 70 years. The mean disease duration was 9.9±6.9 years. The most prevalent comorbidities were depression (47.2%), hypertension (44.0%), and type 2 diabetes mellitus (21.5%). The logistic regression analysis revealed that hallucinations, amantadine, and catechol-O-methyltransferase inhibitors (entacapone) were independently associated with falls in PD patients. Also, hallucinations, dyskinesia, and the use of amantadine were independently associated with recurrent falls. Conclusions: Health care providers play an essential role in fall prevention in PD patients, particularly by identifying older adults experiencing dyskinesia and visual hallucinations. Prospective studies should investigate the use of amantadine as a risk factor for falls in PD patients.
- 1 June 2022
- Published by FapUNIFESP (SciELO) in Dementia & Neuropsychologia
- Vol. 16 (2) , 153-161
Open AccessFalls in Parkinson's disease: the impact of disease progression, treatment, and motor complications
The prevalence of Parkinson's disease (PD) tends to increase worldwide in the coming decades. Thus, the incidence of falls is likely to increase, with a relevant burden on the health care system. Objective: The objective of this study was to evaluate clinical factors and drug use associated with falls in PD patients. Methods: We conducted a cross-sectional study at the Movement Disorders outpatient clinic of a tertiary hospital in Northeast Brazil. We performed structured interviews to collect sociodemographic and clinical data. Functional capacity was assessed using the Schwab and England Activities of Daily Living Scale and the modified Hoehn and Yahr Staging Scale. We divided the study sample into non-fallers (no falls) and fallers (≥1 fall), and non-recurrent (≤1 fall) and recurrent fallers (>1 fall). Results: The study population comprised 327 PD patients (48% women), with a mean age of 70 years. The mean disease duration was 9.9±6.9 years. The most prevalent comorbidities were depression (47.2%), hypertension (44.0%), and type 2 diabetes mellitus (21.5%). The logistic regression analysis revealed that hallucinations, amantadine, and catechol-O-methyltransferase inhibitors (entacapone) were independently associated with falls in PD patients. Also, hallucinations, dyskinesia, and the use of amantadine were independently associated with recurrent falls. Conclusions: Health care providers play an essential role in fall prevention in PD patients, particularly by identifying older adults experiencing dyskinesia and visual hallucinations. Prospective studies should investigate the use of amantadine as a risk factor for falls in PD patients.